Knockdown of LTA4H has been shown to inhibit the proliferation of ovarian cancer cells, while high expression of LTA4H leads to a decrease in infiltrating CD8+ T cells, which are crucial for anti-tumor immune responses. The gene discussed is LTA4H; the disease is ovarian cancer.